America has a long history of enacting sound, bipartisan policies that have created powerful incentives for life sciences innovators to invest in the costly, extensive research and development (R&D) process behind groundbreaking treatments and cures. These pro-innovation policies have been carefully balanced by market protections that promote access to a wide range of treatment options for patients.

read more